tallózása szerző szerint "Wali VB"

A találatok rendezése: Rendezés: Találatok:

  • miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer 
    Adams BD; Wali VB; Cheng CJ; Inukai S; Booth CJ; Agarwal S; Rimm DL; Győrffy, Balázs; Santarpia L; Pusztai L; Saltzman WM; Slack FJ (2016)
    Triple-negative breast cancer (TNBC) is an aggressive subtype with no clinically proven biologically targeted treatment options. The molecular heterogeneity of TNBC and lack of high frequency driver mutations other than ...
  • Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors 
    Perez-Pena J; Alcaraz-Sanabria A; Nieto-Jimenez C; Paez R; Corrales-Sanchez V; Serrano-Oviedo L; Wali VB; Patwardhan GA; Amir E; Győrffy, Balázs; Pandiella A; Ocana A (2017)
    Luminal breast tumors have been classified into A and B subgroups, with the luminal A being associated with a more favorable clinical outcome. Unfortunately, luminal A tumors do not have a universally good prognosis. We ...
  • Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis 
    Jiang T; Shi W; Wali VB; Pongor, Lőrinc; Li C; Lau R; Győrffy, Balázs; Lifton RP; Symmans WF; Pusztai L; Hatzis C (2016)
    Background: Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease, and although no effective targeted therapies are available to date, about one-third of patients with TNBC achieve pathologic ...